
Methtat-NP Tablet SR
Marketer
Natchem Pharma
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Methtat-NP Tablet SR
Methtat-NP SR tablets are a dual-action formulation for neuropathic pain management. This medication reduces pain signals by modulating nerve cell calcium channels. Simultaneously, it boosts brain neurotransmitters, improving mood regulation and nerve fiber protection. Methtat-NP SR may be administered with or without food, but consistent daily timing ensures optimal therapeutic levels. Always adhere to your physician's prescribed dosage and duration. Missed doses should be taken promptly upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is strongly discouraged, as it could exacerbate symptoms. Commonly reported side effects include constipation, weight increase, and dry mouth. Dizziness and drowsiness may occur; avoid activities requiring alertness until the medication's effects are understood. Weight gain is possible; a balanced diet and regular exercise can help mitigate this. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all other medications being taken, as potential interactions may affect efficacy or mechanism. Inform your physician of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Methtat-NP Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Methtat-NP Tablet SR
Managing Neuropathic Pain
Major Benefits of Methtat-NP Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Methtat-NP Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Methtat-NP Tablet SR:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Methtat-NP Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Methtat-NP Tablet SR whole; do not crush, chew, or divide it. This medication can be taken with or without food, but consistency in timing is recommended.
How Methtat-NP Tablet SR works:
Methtat-NP SR tablets contain pregabalin, nortriptyline, and methylcobalamin, working synergistically to manage neuropathic pain. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain transmission by modulating nerve cell calcium influx. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal propagation in the brain. Methylcobalamin, a B vitamin, supports myelin sheath production and repair, protecting and restoring nerve fiber health. This combined action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Methtat-NP extended-release tablets and alcohol can lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The extended-release Methtat-NP tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Methtat-NP tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Methtat-NP Tablet SR, due to potential drowsiness induced by the medication.
KidneyCAUTION
Patients with impaired kidney function should use Methtat-NP Tablet SR with careful monitoring. Dosage modification of Methtat-NP Tablet SR may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Methtat-NP Tablet SR appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification of Methtat-NP Tablet SR may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Methtat-NP Tablet SR :
Should you forget a Methtat-NP Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Methtat-NP Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
